Revolution MedicinesSan Francisco Bay Area2026-02-27
[Industry: Biotechnology Research | Type: Full-time | Level: Mid-Senior level] Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier…
Read full description
[Industry: Biotechnology Research | Type: Full-time | Level: Mid-Senior level] Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. Th
Revolution MedicinesSan Francisco Bay Area2026-02-18
[Industry: Biotechnology Research | Type: Full-time | Level: Director] Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in…
Read full description
[Industry: Biotechnology Research | Type: Full-time | Level: Director] Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The compan
Revolution MedicinesSan Francisco Bay Area2026-02-06
[Industry: Biotechnology Research | Type: Full-time | Level: Mid-Senior level] Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier…
Read full description
[Industry: Biotechnology Research | Type: Full-time | Level: Mid-Senior level] Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. Th
[Applicants: Be among the first 25 applicants | Industry: Biotechnology Research and Pharmaceutical Manufacturing | Type: Full-time | Level: Director] Revolution Medicines is a clinical-stage precision oncology company…
Read full description
[Applicants: Be among the first 25 applicants | Industry: Biotechnology Research and Pharmaceutical Manufacturing | Type: Full-time | Level: Director] Revolution Medicines is a clinical-stage precision oncology company focused on developing novel ta